Archives

Platinum Equity to Acquire Sunrise Medical

Investment in Germany-based maker of wheelchairs and mobility solutions adds to momentum of Platinum’s European investment team

LOS ANGELES (June 5, 2024) – Platinum Equity announced today the signing of a definitive agreement to acquire Sunrise Medical, a world leader in advanced assistive mobility solutions, from Nordic Capital.

Financial terms were not disclosed. The acquisition is expected to be completed in Q3 2024, subject to customary regulatory approvals.

Sunrise Medical, a global market leader for assistive mobility solutions, is active in the development, design, manufacturing, and distribution of assistive mobility products and solutions such as manual and power wheelchairs, power assist products, pediatric and geriatric therapeutic devices, mobility scooters, seating and positioning systems as well as daily living aids and other home medical equipment. Products are marketed under the Quickie, RGK, Magic, JAY, Zippie, Leckey, Breezy, Sterling and other proprietary brands and are sold through a network of homecare medical product dealers or distributors in over 130 countries.

Headquartered in Malsch, Germany with North American headquarters in Fresno, California, the company has manufacturing facilities in the United States, Mexico, Germany, United Kingdom, Spain, and China.

“Sunrise Medical is an innovative, global company that has been a pioneer in mobility solutions for more than 40 years,” said Platinum Equity Co-President Louis Samson. “We believe strongly in the company’s core mission and are committed to partnering with the management team to continue investing in development of advanced clinical solutions tailored to the individual needs of people who depend on them.”

Thomas Babacan, President and CEO of Sunrise Medical, will continue leading the company following the transition to new ownership.

“We are a purpose-driven company with the ability to positively impact people’s lives,” said Babacan. “As we continue to innovate and grow, we have the opportunity to be impactful on an even larger scale. Platinum has a lot of experience supporting complex, global businesses and the firm’s financial resources and operational expertise will be especially valuable to our mission. We are excited about the opportunities ahead.”

The acquisition is being led by Platinum Equity’s European investment team based in London.

“Sunrise Medical has established an impressive global network serving the mobility needs of people around the world,” said Platinum Equity Managing Director Igor Chacartegui. “We will continue investing in organic growth and also pursue acquisitions that can expand or fill in gaps in the company’s product line, provide new technological capabilities, or further extend the company’s geographic reach.”

JP Morgan is serving as financial advisor to Platinum Equity on the acquisition of Sunrise Medical. Willkie Farr & Gallagher LLP is providing legal counsel and Latham & Watkins LLP is providing regulatory counsel to Platinum Equity on the transaction.

About Platinum Equity

Founded in 1995 by Tom Gores, Platinum Equity is a global investment firm with more than $48 billion of assets under management and a portfolio of approximately 50 operating companies that serve customers around the world. Platinum Equity specializes in mergers, acquisitions and operations – a trademarked strategy it calls M&A&O® – acquiring and operating companies in a broad range of business markets, including manufacturing, distribution, transportation and logistics, equipment rental, metals services, media and entertainment, technology, telecommunications and other industries. Over the past 28 years Platinum Equity has completed more than 450 acquisitions.

About Sunrise Medical

Committed to improving people’s lives, Sunrise Medical is a global leader in the development, design, manufacturing, and distribution of innovative, high-quality assistive mobility devices and services. Distributed in more than 130 countries under its own 18 proprietary brands, the key products include manual and power wheelchairs, power assist products, pediatric and geriatric therapeutic devices, mobility scooters, daily living aids and more. Operating in 23 countries, Sunrise Medical Group is headquartered in Malsch, Germany and employs over 2,800 associates worldwide. For further information, please visit: https://sunrisemedical-group.com/.

Categories: News

Tags:

Emera Completes Transaction To Transfer Equity Interest In Labrador Island Link

KKR

HALIFAX, Nova Scotia–(BUSINESS WIRE)–Emera Inc. (“Emera”) (TSX:EMA) today announced the previously announced transaction where KKR would acquire Emera’s indirect minority equity interest in the Labrador Island Link (LIL), has closed effective today. The LIL is a 1,100 km high voltage transmission line that delivers renewable energy to Newfoundland, Nova Scotia and beyond, helping meet the growing demand for clean energy across the region. The transaction was originally announced on May 28, 2024.

About Emera
Emera Inc. is a geographically diverse energy and services company headquartered in Halifax, Nova Scotia, with approximately $39 billion in assets and 2023 revenues of $7.6 billion. The company primarily invests in regulated electricity generation and electricity and gas transmission and distribution with a strategic focus on transformation from high carbon to low carbon energy sources. Emera has investments in Canada, the United States and in three Caribbean countries. Emera’s common and preferred shares are listed on the Toronto Stock Exchange and trade respectively under the symbol EMA, EMA.PR.A, EMA.PR.B, EMA.PR.C, EMA.PR.E, EMA.PR.F, EMA.PR.H, EMA.PR.J and EMA.PR.L. Depositary receipts representing common shares of Emera are listed on the Barbados Stock Exchange under the symbol EMABDR and on The Bahamas International Securities Exchange under the symbol EMAB. Additional information can be accessed at www.emera.com or at www.sedarplus.ca.

Forward Looking Information
This news release contains forward‐looking information within the meaning of applicable securities laws, including statements concerning the acquisition of Emera’s indirect interest in the LIL by KKR, Emera’s future financial performance, the service life of the LIL, Emera’s engagement in the LIL, including future sustaining capital investments, and market conditions and demand for clean energy in Atlantic Canada in the future. Undue reliance should not be placed on this forward-looking information, which applies only as of the date hereof. By its nature, forward‐looking information requires Emera to make assumptions and is subject to inherent risks and uncertainties. These statements reflect Emera management’s current beliefs and are based on information currently available to Emera management. There is a risk that predictions, forecasts, conclusions and projections that constitute forward‐looking information will not prove to be accurate, that Emera’s assumptions may not be correct and that actual results may differ materially from such forward‐looking information. Additional detailed information about these assumptions, risks and uncertainties is included in Emera’s securities regulatory filings, including under the heading “Business Risks and Risk Management” in Emera’s annual Management’s Discussion and Analysis, and under the heading “Principal Risks and Uncertainties” in the notes to Emera’s annual and interim financial statements, which can be found on SEDAR+ at www.sedarplus.ca.

Contacts

Media
Dina Bartolacci Seely
media@emera.com

 

DOWNLOAD PDF

Categories: News

Tags:

KKR Exceeds Acceptance Threshold For Voluntary Public Takeover Offer For ENCAVIS AG

KKR
  • Minimum acceptance threshold of 54.285%1 has been exceeded within the initial acceptance period
  • Acceptance rate amounts to 68.55 percent of all outstanding ENCAVIS AG shares
  • Additional acceptance period to run from 5 June 2024 until 18 June 2024
  • Post-settlement, KKR and the Management Board of Encavis intend to delist Encavis from the stock exchange as soon as legally and practically possible after closing

4 June 2024 – Elbe BidCo AG (the “Bidder”), a holding company controlled by investment funds, vehicles and accounts advised and managed by Kohlberg Kravis Roberts & Co. L.P. and its affiliates (collectively, “KKR”), today announced the result of the initial acceptance period of the voluntary public takeover offer (the “Takeover Offer”) for the shares (ISIN: DE0006095003 / DE0006095003) of ENCAVIS AG (“Encavis”).

At the expiry of the period at 24:00 hrs (local time Frankfurt am Main) on 29 May 2024, the takeover offer had been accepted for 59,899,783 Encavis shares. This corresponds to approximately 68.55 percent of all outstanding Encavis shares, including the ca. 18% of Encavis shares that ABACON and other shareholders will sell and the ca. 13% of Encavis shares that ABACON and other shareholders will roll-over to Bidder under binding agreements. As such, the minimum acceptance threshold of 54.285% has been exceeded.

Post-settlement, Bidder intends to delist Encavis from the stock exchange as soon as legally and practically possible after closing to benefit from financial flexibility and a long-term commitment of KKR and Viessmann under private ownership.

“We are thrilled to have reached this milestone and believe that the long-term vision and financial flexibility of private ownership will unlock significant opportunities for growth and innovation,” said Vincent Policard, Partner and Co-Head of European Infrastructure at KKR. “The intended delisting is the next logical step in this direction, providing Encavis with the flexibility to focus on their core objectives, and creating an even more dynamic framework for the company to thrive in the rapidly evolving energy sector.”

Encavis shareholders continue to have the opportunity to accept the offer within the additional acceptance period, which will start on 5 June 2024 and expire on 18 June 2024 at 24:00 hours (local time Frankfurt am Main).

The voluntary public takeover offer remains subject to the completion of the regulatory conditions outlined in sections 12.1.1, 12.1.3 (ii) to (vii) and 12.1.4 of the offer document. Closing of the transaction is expected in Q4 2024.

On 14 March 2024, Bidder had launched a voluntary public takeover offer for all outstanding free float shares of Encavis. Viessmann invests as a shareholder in a KKR-led consortium.

The offer document and additional information are available at www.elbe-offer.com.

1 This accounts for potential dilution of existing shareholders from conversion of the hybrid convertible bonds; equivalent to 50% plus one share in case of a conversion of all of the hybrid convertible bonds.

###

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries.

 

KKR established its Global Infrastructure business in 2008 and has since grown to one of the largest infrastructure investors globally with a team of more than 115 dedicated investment professionals. The firm currently oversees approximately USD 59 billion in infrastructure assets globally as of 31 December 2023, and has made over 80 infrastructure investments across a range of sub-sectors and geographies. KKR’s infrastructure platform is devised specifically for long-term, capital intensive structural investments.

 

For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

 

About Viessmann

Founded in 1917, the independent family company Viessmann is today a global, broadly diversified Group. All activities are based on the company’s purpose “We co-create living spaces for generations to come”. This is the passion and responsibility that the large worldwide Viessmann family brings to life every day. Following this purpose, Viessmann forms an ecosystem of entrepreneurs and co-creators with a clear focus on CO2 avoidance, CO2 reduction and CO2 capturing.

 

About ABACON

ABACON CAPITAL, a family-owned investment firm, champions the sustainable energy transition, pioneering mobility solutions, and groundbreaking deep tech. Our mission centers on uplifting communities, fostering purposeful endeavors, and ensuring profitability, all while advancing societal and environmental well-being.

 

Founded by Albert Büll, a visionary entrepreneur and investor with a legacy in nurturing sustainable enterprises – such as B&L Group in real estate development, Encavis AG in renewable energy production, and noventic in smart metering and energy management – ABACON is built on a foundation of innovation and responsibility.

 

About Encavis

The Encavis AG (Prime Standard; ISIN: DE0006095003; ticker symbol: ECV) is a producer of electricity from Renewable Energies listed on the MDAX of Deutsche Börse AG. As one of the leading independent power producers (IPP), Encavis acquires and operates (onshore) wind farms and solar parks in twelve European countries. The plants for sustainable energy production generate stable yields through guaranteed feed-in tariffs (FIT) or long-term power purchase agreements (PPA). The Encavis Group’s total generation capacity currently adds up to more than 3.5 gigawatts (GW), of which around 2.2 GW belong to the Encavis AG, which corresponds to a total saving of around 0.8 million tonnes of CO2 per year stand-alone for the Encavis AG. In addition, the Group currently has around 1.2 GW of capacity under construction, of which around 830 MW are own assets.

 

Within the Encavis Group, Encavis Asset Management AG offers fund services to institutional investors. Another Group member company is Stern Energy S.p.A., based in Parma, Italy, a specialised provider of technical services for the installation, operation, maintenance, revamping and repowering of photovoltaic systems across Europe.

 

Encavis is a signatory of the UN Global Compact as well as of the UN PRI network. Encavis AG’s environmental, social and governance performance has been awarded by two of the world’s leading ESG rating agencies. MSCI ESG Ratings awarded the corporate ESG performance with their “AA” level and ISS ESG with their “Prime” label (A-).

 

Additional information can be found on www.encavis.com

 

 

KKR media contact

 

Thea Bichmann

Mobile: +49 (0) 172 13 99 761

Email: kkr_germany@fgsglobal.com

 Emily Lagemann

Mobile: +49 (0) 171 86 79 950

Email: kkr_germany@fgsglobal.com

 

 

Viessmann media contact

 

Byung-Hun Park

Vice President Corporate Communication

Mobile: + 49 (0) 151 64911317

Email: huni@viessmann.com

  

 

Disclaimer and forward-looking statements

This press release is neither an offer to purchase nor a solicitation of an offer to sell Encavis shares. The final terms of the takeover offer, as well as other provisions relating to the takeover offer are set out solely in the offer document authorized for publication by the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht). Investors and holders of Encavis shares are strongly advised to read the offer document and all other documents relating to the takeover offer, as they contain important information. The offer document for the takeover offer (in German and a non-binding English translation) with the detailed terms and conditions and other information on the takeover offer is published amongst other information on the internet at www.elbe-offer.com.

The takeover offer will be implemented exclusively on the basis of the applicable provisions of German law, in particular the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz – WpÜG), and certain securities law provisions of the United States of America relating to cross-border takeover offers. The takeover offer will not be conducted in accordance with the legal requirements of jurisdictions other than the Federal Republic of Germany or the United States of America (as applicable). Accordingly, no notices, filings, approvals or authorizations for the takeover offer have been filed, caused to be filed or granted outside the Federal Republic of Germany or the United States of America (as applicable). Investors and holders of Encavis shares cannot rely on being protected by the investor protection laws of any jurisdiction other than the Federal Republic of Germany or the United States of America (as applicable). Subject to the exceptions described in the offer document and, where applicable, any exemptions to be granted by the respective regulatory authorities, no takeover offer will be made, directly or indirectly, in those jurisdictions in which this would constitute a violation of applicable law. This press release may not be released or otherwise distributed in whole or in part, in any jurisdiction in which the takeover offer would be prohibited by applicable law.

The Bidder reserves the right, to the extent permitted by law, to directly or indirectly acquire additional Encavis shares outside the takeover offer on or off the stock exchange, provided that such acquisitions or arrangements to acquire are not made in the United States, will comply with the applicable German statutory provisions, in particular the WpÜG, and the offer price is increased in accordance with the WpÜG, to match any consideration paid outside of the takeover offer if higher than the offer price. If such acquisitions take place, information on such acquisitions, including the number of Encavis shares acquired or to be acquired and the consideration paid or agreed, will be published without undue delay if and to the extent required under the laws of the Federal Republic of Germany, the United States or any other relevant jurisdiction. The takeover offer relates to shares in a German company admitted to trading on the Frankfurt Stock Exchange and Hamburg Stock Exchange and is subject to the disclosure requirements, rules and practices applicable to companies listed in the Federal Republic of Germany, which differ from those of the United States and other jurisdictions in certain material respects. The financial information relating to the Bidder and Encavis included elsewhere, including in the offer document, are prepared in accordance with provisions applicable in the Federal Republic of Germany and are not prepared in accordance with generally accepted accounting principles in the United States; therefore, it may not be comparable to financial information relating to United States companies or companies from other jurisdictions outside the Federal Republic of Germany. The takeover offer will be made in the United States pursuant to Section 14(e) of, and Regulation 14E under, the Exchange Act, and on the basis of the so-called Tier II exemption from certain requirements of the Exchange Act, which exemption allows a bidder to comply with certain substantive and procedural rules of the Exchange Act for takeover bids by complying with the law or practice of the domestic legal system and exempts the bidder from complying with certain other rules of the Exchange Act, and otherwise in accordance with the requirements of the laws of the Federal Republic of Germany. Shareholders from the United States should note that Encavis is not listed on a United States securities exchange, is not subject to the periodic requirements of the Exchange Act and is not required to, and does not, file any reports with the United States Securities and Exchange Commission.

Any contract entered into with the Bidder as a result of the acceptance of the takeover offer will be governed exclusively by and construed in accordance with the laws of the Federal Republic of Germany. It may be difficult for shareholders from the United States (or from elsewhere outside of Germany) to enforce certain rights and claims arising in connection with the takeover offer under United States federal securities laws (or other laws they are acquainted with) since the Bidder and Encavis are located outside the United States (or the jurisdiction where the shareholder resides), and their respective officers and directors reside outside the United States (or the jurisdiction where the shareholder resides). It may not be possible to sue a non-United States company or its officers or directors in a non-United States court for violations of United States securities laws. It also may not be possible to compel a non-United States company or its subsidiaries to submit themselves to a United States court’s judgment.

To the extent that this press release contains forward-looking statements, they are not statements of fact and are identified by the words “intend”, “will” and similar expressions. These statements express the intentions, beliefs or current expectations and assumptions of the Bidder and the persons acting jointly with it. Such forward- looking statements are based on current plans, estimates and projections made by the Bidder and the persons acting jointly with it to the best of their knowledge, but are not guarantees of future accuracy (this applies in particular to circumstances beyond the control of the Bidder or the persons acting jointly with it). Forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and are usually beyond the Bidder’s control or the control of the persons acting jointly with it. It should be taken into account that actual results or consequences in the future may differ materially from those indicated or contained in the forward-looking statements. It cannot be ruled out that the Bidder and the persons acting jointly with it will in future change their intentions and estimates stated in documents or notifications or in the offer document.

 

 

 

DOWNLOAD PDF

Categories: News

Tags:

Gamma Biosciences Announces Sale Of Mirus Bio To Merck For $600 Million

KKR

MENLO PARK, Calif. and MADISON, Wis., May 23, 2024 – Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, today announced that it has entered into an agreement with Merck (XTRA:MRK), a leading science and technology company, whereby Merck will acquire Gamma operating company Mirus Bio for $600 million in cash.

Mirus Bio is a leading provider of innovative transfection solutions used for the delivery of genetic material into cells. The company offers a comprehensive portfolio of RUO and GMP reagents and enhancers based on proprietary, multi-component technology. Its products deliver high-performance and cost-effective transfection for a variety of applications, from research through virus manufacturing at scale to address rapidly growing cell and gene therapy applications in AAV & LV.

Gamma acquired a controlling stake in Mirus Bio in 2021 and has worked closely with the company to support its growth and scale-up, including the launch of flagship products VirusGEN® GMP and RevIT™ AAV Enhancer for large-scale therapeutic adeno-associated virus and lentivirus production.

“Over the last several years, we have had the pleasure of supporting Dale and the team at Mirus as they have worked to make these best-in-class transfection products available to cell and gene therapy developers while maintaining the company’s long-standing commitment to the research community” said Matt Gunnison, CEO of Gamma Biosciences. “We are very proud of the progress that Mirus has made and are delighted that it will now become part of Merck, who we believe is the ideal partner to continue this strong trajectory.”

Dale Gordon, Chief Executive Officer of Mirus Bio, added “With the support of Gamma Biosciences and KKR, we have commercialized our scalable GMP delivery platforms for clinical use and significantly strengthened our position in the cell and gene therapy market. I look forward to this new era with Merck as we continue to expand our GMP portfolio with relevant, cutting-edge tools our customers need to develop affordable, life-saving advanced therapies.”

“Gamma’s investment in Mirus Bio reflects KKR’s commitment to driving innovation in the life sciences sector,” said Kugan Sathiyanandarajah, Partner at KKR and Head of Europe for KKR’s Health Care Strategic Growth strategy, and Anuv Ratan, Director at KKR. “The advancements achieved together with the Mirus team, from scaling commercial operations to launching new product lines, further underscore the strong value-creation potential of our strategic approach.”

The transaction is expected to be completed in the third quarter of 2024, subject to US regulatory approvals, as well as other customary closing conditions. Jefferies LLC acted as financial advisor to Gamma and Sidley Austin LLP acted as legal advisors to Gamma.

About Gamma Biosciences
Gamma Biosciences is a leading life sciences platform providing products and services to support the development and manufacturing of advanced biologic therapies. Our operating companies are committed to advancing the science and art of bioprocessing by delivering market-ready innovation and expertise that helps our customers.

About Mirus Bio
Mirus Bio is a leading provider of transfection products for the biopharmaceutical and research industries, offering best-in-class reagents for gene therapy, recombinant protein, and stem cell applications. A pioneer in nucleic acid delivery, the company has been enabling scientific research and innovation for more than two decades. In 2021, Mirus introduced VirusGEN® GMP Transfection Reagent and Enhancers to address the commercial biopharmaceutical and cell and gene therapy markets with support for virus manufacturing, gene editing, and biotherapeutic protein production.

About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

 

Media Contacts

Mirus Bio
Nat Connors
Mobil: +608 867-6465
E-Mail: nat.connors@mirusbio.com

KKR
FGS Global
Alastair Elwen
+44 20 7251 3801
KKR-Lon@FGSGlobal.com

KKR Germany
Thea Bichmann
M: +49 172 13 99 761
kkr_germany@fgsglobal.com

 

DOWNLOAD PDF

Categories: News

Tags:

Consor Holdings Announces Growth Investment from New Mountain Capital

No Comments
New Mountain Capital

New York, NY – June 3, 2024 – Consor Holdings LLC (“Consor” or the “Firm”), a leading provider of transportation and water infrastructure engineering and consulting services, and New Mountain Capital, LLC (“New Mountain”), a leading growth-oriented investment firm with approximately $50 billion in assets under management, today announced a significant investment from affiliates of New Mountain to support the Firm’s continued growth. Consor’s leadership team and employees retained a significant ownership stake in the Firm.

With roots dating back over 40 years, Consor provides civil infrastructure planning, engineering design, structural assessment, program management, and consulting services to public and private sector clients across transportation and water markets. Consor is well-established in the largest, growing markets within North America.

“New Mountain is our ideal partner. They believe in our long-term vision and bring extensive industry experience that will help us expand our potential,” said Chris Rayasam, CEO of Consor. “We’re excited about the many ways New Mountain will help support our growth through strategic planning, technology enablement and operational efficiency. This partnership will cultivate more career opportunities for our team members and make an even greater impact on the communities we serve.”

Lars Johansson, Managing Director at New Mountain, said, “Our investment in Consor is the result of New Mountain’s long-standing effort investing in infrastructure services and technology businesses. Chris and the leadership team have built an outstanding business with expertise in key end markets we believe in and that have continual growth opportunities. We are excited to partner with the entire Consor team to continue their strategy of building a legacy as the team of choice for delivering infrastructure solutions.”

“We are thrilled to be partnering with Consor to continue to elevate their brand as industry leaders” said Joe Walker, Managing Director at New Mountain. “We are looking forward to helping Consor expand its geographic reach and service offerings, through a combination of best-in-class organic growth and strategic M&A, to achieve its long-term vision.”

As part of this transaction, Keystone Capital will fully sell its stake in the business after a strong, multi-year partnership with Consor.

“Chris and his team have built an incredible firm with full-service capabilities and an exemplary reputation, and we’ve been proud to support them in their journey,” said Scott Gwilliam, Managing Partner at Keystone Capital. “Consor has tremendous growth potential, and we wish the team great success for the next chapter.”

AEC Advisors LLC served as financial advisor and Ropes & Gray LLP served as legal advisor to New Mountain Capital. Harris Williams and Houlihan Lokey served as financial advisors and DLA Piper served as legal advisor to Consor and Keystone Capital.

++

About Consor
Consor is a leading North American transportation and water infrastructure consulting firm offering planning, engineering design, structural assessment, program management, and construction services. Consor has deep relationships with state departments of transportation, municipalities, utilities and other public and private clients throughout the United States and Canada. With over 1,700 employees, Consor is focused on going above, below, and beyond the surface to move people and communities forward by maintaining and improving critical infrastructure. For more information on Consor, please visit https://www.consoreng.com/.

About New Mountain Capital

New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, credit and net lease investment strategies with over $50 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit https://www.newmountaincapital.com/.

About Keystone Capital

Keystone was founded in 1994 with the objective of investing the personal capital of its partners in high quality, market-leading businesses; patiently building long-term value alongside management through organic growth and strategic acquisitions. Keystone currently manages over $1 billion in capital across two funds. To maintain consistency with its historical investment strategy and align interest across all stakeholders, the principals of Keystone collectively represent the largest single investor in both of these funds, which have been structured with an extended life to support Keystone’s belief in investment period flexibility. In addition to its long history investing in engineering services, Keystone focuses on professional & tech-enabled services, technical services, commercial & industrial services, food & beverage manufacturing, and industrial technology. For more information on Keystone Capital, please visit https://keystonecapital.com/.

Media Contacts

Consor

Whitney Janoska

Consor

Whitney.janoska@consoreng.com

New Mountain Capital

Dana Gorman

H/Advisors Abernathy

(212) 237–5999

dana.gorman@h-advisors.global

Keystone Capital

Erik Gernant

Keystone Capital Management, LP

(312) 219-7969

egernant@keystonecapital.com

Categories: News

Tags:

Vendis Capital enters the cosmetic treatment market with the acquisitions of SOAP and BM Clinics

Vendis Capital

Vendis Capital, the European private equity fund specialized in the consumer sector, joins forces with the founders and management of 2 leading Dutch cosmetic clinic chains: SOAP and BM Clinics. Through further acquisitions and the opening of new clinics, the aim is to make the high quality treatments offered by these clinics available to an even larger group of consumers.

Cosmetic treatments are rapidly gaining popularity. Growing interest among women – and also increasingly men – in wellness and personal care has led to strong growth in a wide range of beauty, skin, laser and injectables (botox and fillers) treatments. Over 90% of Dutch people now have a positive or neutral opinion of these products and services, providing a strong foundation for further growth in the years to come.

For the most part, these treatments are still offered in small independent clinics in the Netherlands. Today, the new group has 17 clinics and plans to continuously expand this number. It is precisely because of the scale offered by the new group that the highest quality standards can be guaranteed, the latest treatments offered by the best practitioners and the company can remain at the forefront of quality and service.

SOAP was founded in Amsterdam in 2005 by sisters Esther and Stephanie Litjens. They brought a unique concept – inspired by ‘New York City Spa’s’ – to the Netherlands. SOAP has grown into a premium chain of boutique clinics in the Netherlands with a wide range of beauty treatments – from manicures to facials and from injectables to laser hair removal – and excellent service. Doctor David Mosmuller joined in 2019 to further expand the injectables treatments. The focus is on offering a more natural appearance according to the ‘no trace face’ principle; a fresher, younger appearance without looking treated. Today, SOAP is active in seven cities in the Netherlands with its unique concept.

BM Clinics was started in Eindhoven in 2013 by Monique Vonken and is a value-for-money provider, mainly of injectables. BM has a clear focus on making high-quality treatments accessible to a broad target group through affordable prices. BM sets the highest standards in terms of quality and service, with treatments carried out exclusively by doctors. Today, BM Clinics is active in nine cities in the Netherlands with its affordable concept.

Management of the new group includes Stephanie Litjens and David Mosmuller and is headed by newly appointed CEO David Sloff. David brings considerable experience from his previous roles at Diageo and Procter & Gamble. “I am impressed with the strong brands the founders have established. I look forward to accelerating the company’s growth together, supported by Vendis Capital’s expertise in building brands and their experience in rolling out winning concepts.”

Vendis Capital partner Vincent Braams: “We are excited about the market for non-invasive cosmetic treatments and see SOAP and BM Clinics as strong leaders in this rapidly growing and fragmented market. The group is well positioned to become a European leader through its unique consumer offerings, an experienced and reputable team of physicians, practitioners and staff, and a strong management team. Through the opening of new clinics and an active buy & build strategy we will together accelerate the growth of the group. We already expect to make additional acquisitions in the near future and add these clinics to the group.”

The acquisition of SOAP and BM Clinics and the subsequent formation of the new group represents the first investment for Vendis Capital IV.

Categories: News

Tags:

MyDefence, the counter drone technology provider, announces Bridgepoint as new majority shareholder

Bridgepoint
  • MyDefence, a Danish specialist developer of counter drone technology, announces new investment via the Bridgepoint Development Capital IV fund.
  • Bridgepoint will support MyDefence in its next stage of growth, including further investments in research and development as well as production expansion.

 

MyDefence, a leading provider of counter unmanned aerial systems, known as C-UAS or counter drone technology, has announced the global private equity group, Bridgepoint, as its new majority shareholder. The partnership leverages Bridgepoint’s strong track record of supporting international expansion and growth in global technology and advanced industrial sectors. The investment was made via Bridgepoint Development Capital IV (“BDC”), a fund focused on investing in mid-market growth business across Europe.

MyDefence develops radio frequency-powered products to detect and defeat unmanned aerial systems, such as drones. The company’s products can be worn by personnel or mounted to vehicles and buildings, and its technology is used to protect military or civilian critical infrastructure from the safety risks posed by hostile drones. The company has delivered 115% compound annual revenue growth over the last four years and is well-positioned to become a leader in the $1.1 billion addressable market for drone countermeasure solutions with its unique product offering.

With access to capital and strategic support from Bridgepoint, MyDefence is advantageously placed to expand its reach globally and reinforce its position as a leader in C-UAS and other technologies with civil and defence applications. The partnership will enable MyDefence’s next phase of growth with a focus on the scaling of production, professionalization, and research and development.

Dan Hermansen, CEO at MyDefence, said:

“We are delighted to partner with the Bridgepoint team. Their extensive presence worldwide and their experience helping companies grow is valuable to us. Adding us to Bridgepoint’s vast network not only gives us financial support, but it also puts us on a path for faster development and innovation. C-UAS systems are among the most important next-generation defence technologies and MyDefence is at the forefront of all cutting-edge innovations required to meet the difficulties facing drone defence today.”

Johan Gustafsson, Partner at Bridgepoint Development Capital, said:

“We have built a very strong relationship with Dan and his team, whose wealth of experience bridges the defence and security arenas. With a suite of products at the forefront of technology, MyDefence enjoys an enviable position in the market, underpinned by a robust orderbook and pipeline with significant scale-up opportunities. We look forward to leveraging the complete breadth of capabilities across our international network to help realise this exciting next stage of MyDefence’s journey.” 

 

Poised for global expansion and further innovation

With a significant number of C-UAS systems supplied already, MyDefence has proven to be a dependable technology-provider in the defence industry. With the support of Bridgepoint, MyDefence is now ready to expand its technology offering, not only in defence but additionally in corporate, governmental and homeland security sectors.

This reflects the growing demand for comprehensive security measures against hostile drone threats across a range of applications, including the protection of critical infrastructure, including utilities like gas and electricity, public venues like stadia and event spaces, and high-security institutions such as prisons.

Financial terms of the transaction were not disclosed.

MyDefence was advised by PwC (M&A adviser), Plesner (legal adviser), and KPMG (financial and tax adviser). Bridgepoint was advised by SEB (M&A adviser), Accura (legal adviser, tax due diligence and structuring), Renaissance Strategic Advisers (commercial due diligence), Alvarez & Marsal (financial and operational due diligence), Crosslake (technology due diligence), ERM (ESG due diligence), and Marsh (insurance due diligence).

Bridgepoint is one of the world’s leading quoted private asset growth investors, specialising in private equity, infrastructure and private credit.

With over €67bn of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market insight and sector expertise, consistently delivering strong returns through cycles.

Bridgepoint Advisers Limited, a subsidiary of Bridgepoint Group plc, is authorised and regulated by the Financial Conduct Authority.

Categories: News

Tags:

Hudson Yards Experiences Appoints Andrew Lustgarten As Executive Chairman

No Comments
KKR

Expands Senior Leadership Team with Hires of Francesca Merlino as Chief Commercial Officer and Joseph Wittmann as General Manager

 

NEW YORK—June 3, 2024—Hudson Yards Experiences (“HYE”), operator of Edge (the highest indoor/outdoor sky deck in the Western Hemisphere), CityClimb (the world’s highest aerial adventure course) and Peak (restaurant, bar and private event business), today announced the appointment of longtime entertainment, media and sports executive, Andrew Lustgarten, to the new role of Executive Chairman of HYE.

Joining HYE’s newly created senior leadership team headed by Mr. Lustgarten are Francesca Merlino as Chief Commercial Officer and Joseph Wittmann as General Manager. The new appointments bolster HYE’s strong operating capabilities and team, positioning HYE’s portfolio of marquee New York City attractions for continued growth and success.

“HYE presents a tremendous opportunity to build upon a portfolio of already distinguished New York brands,” said Mr. Lustgarten. “Edge offers a unique experiential destination that we will continue to position at the forefront of New York City’s live entertainment market through fresh experiences and partnerships that make it a must-visit destination for locals and visitors alike.”

“Andy’s proven track record of building businesses, driving synergies across multi-venue operating portfolios, and orchestrating inventive consumer activations uniquely position him to lead Edge’s multifaceted business,” said Blaine MacDougald, Partner and Co-Head of KKR’s Strategic Investments Group. “We are delighted to unveil HYE’s newly created senior leadership comprised of executives behind some of the world’s most successful entertainment properties.”

“Hudson Yards’ success is a testament to the visionary talent driving every aspect of the neighborhood, and our commitment to continually investing in forward-thinking leaders like Andy,” said Mike Gilbane, Senior Vice President, Related Companies. “Edge is one of New York City’s most recognizable experiences and we look forward to leveraging Andy’s unparalleled entertainment expertise, alongside our impressive group of new and existing team members, as we continue to grow the business.”

Biographies of HYE’s new senior leadership team:

Andrew Lustgarten, Executive Chairman

 

Mr. Lustgarten is an Executive Advisor to KKR focused on sports and entertainment investment opportunities and was most recently CEO and President of Madison Square Garden Sports Corp. and President of Madison Square Garden Entertainment Corp. where he oversaw the overall business strategy and day-to-day operations for the Companies’ wide range of entertainment franchises, including the New York Knicks, New York Rangers, and Radio City Rockettes as well as world-class venues Madison Square Garden, Radio City Music Hall, The Hulu Theater, The Beacon Theatre, The Chicago Theater, The LA Forum and the development of first-of-its-kind, entertainment venue, Sphere. He was also responsible for leading efforts to identify new initiatives and investments to advance the Companies’ business, such as driving numerous landmark marketing partnership deals across MSG’s portfolio, overseeing MSG’s acquisition of Tao Hospitality Group and Hakkasan and investments in DraftKings and Townsquare Media.

Mr. Lustgarten remains a member of the MSG Sports board of directors and is a member of Parella Motorsports Holdings board of directors.  Prior to joining Madison Square Garden’s family of companies, Mr. Lustgarten held senior positions at the NBA and Cablevision. He also previously served on the board of governors for the NBA and the NHL, the board of directors of Tao Group Hospitality, Boston Calling Music Festival, Tribeca Film Festival and Counter Logic Gaming. He is also Chairman of the Board of the Lustgarten Foundation, the world’s largest private funder of pancreatic cancer research.

Francesca Merlino, Chief Commercial Officer

Mrs. Merlino will join HYE in July from Hornblower Group where she serves as Chief Marketing Officer and is responsible for engaging over 22 million visitors annually across a global portfolio of travel and experience offerings. At Hornblower, she oversees the organization’s marketing strategy, communications, brand, digital, revenue optimization, and analytics teams. Before Hornblower, she spent seven years at The Madison Square Garden Company overseeing media planning and marketing for a diverse array of entertainment and sporting franchises including the Radio City Rockettes, the New York Knicks, and the New York Rangers, as well as over 250 events annually across MSG’s iconic New York and Chicago venues. She spent the first six years of her career in marketing at the Solomon R. Guggenheim Museum. She is a graduate of Fordham University.

Joseph Wittmann, General Manager

Mr. Wittman has over 20 years of experience directing some of the U.S.’s most iconic venues and attractions, including over a decade at The Madison Square Garden Company where he managed renowned performance venues including the 3,600 seat Chicago Theatre and 2,900 seat Beacon Theatre. He spent nearly five years at The Shed, a multi-disciplinary non-profit cultural intuition at Hudson Yards, where he oversaw facilities and operations.

About Hudson Yards Experiences:

Hudson Yards Experiences operates Edge, CityClimb and Peak on behalf of a joint venture ownership group led by KKR and Related.

Edge is the highest indoor/outdoor sky deck in the Western Hemisphere offering unparalleled 360-degree views of New York City’s iconic skyline. Rising 1,131 feet in the air and extending out 65 feet from the 100th floor of 30 Hudson Yards, the outdoor viewing area features a thrilling glass-floor, angled glass walls and outdoor skyline steps from the 100th to 101st floors. The venue’s cantilevered terrace is an iconic part of the New York’s skyline and is featured regularly in film and media worldwide. For more information, please visit: https://www.edgenyc.com/.

CityClimb is the highest open-air building ascent in the world. The aerial adventure course allows guests, secured by harness and escorted by certified guides, to scale the outside of a skyscraper more than 1,200 feet above ground, then lean out and look down from the highest outdoor platform in New York City. For more information, please visit: https://www.edgenyc.com/en/cityclimb.

Peak’s roughly 10,000 square foot restaurant, bar, café and private event space is located on the 101st Floor overlooking Edge. For more information, please visit: https://www.peaknyc.com/.

Media Contacts:

KKR

Miles Radcliffe-Trenner
(212) 750-8300
media@kkr.com

Related Companies

Kathleen Anne Corless
(212) 801-1000
communications@related.com

 

DOWNLOAD PDF

Categories: People

FSN Capital announces three partner promotions

Fsn Capital

FSN Capital Partners (“FSN Capital”) is proud to announce the election of three new partners, recognizing their significant impact on the firm and their contribution to promoting FSN Capital’s ethos and values.

Eskil Koffeld and Niclas Thiel have been elected Partners, and Knut Røsjorde has been elected Operating Partner. The promotions take effect at the end of 2024, bringing FSN Capital’s partner group to 14 across offices in Oslo, Stockholm, Copenhagen and Munich.

Eskil Koffeld, based in Oslo, joined the firm in 2015 as an Associate, with prior experience in investment banking. He plays a key role in the firm’s Services sector strategy. From 2019 to 2020, he contributed to developing FSN Capital’s presence and track record in the DACH region, on secondment in Munich.

Niclas Thiel, based in Stockholm, joined FSN Capital in 2016 as an Investment Director, with prior experience in private equity and investment banking. Niclas is responsible for the firm’s Industrials sector strategy and was previously responsible for resource allocation of the investment advisory team.

Knut Røsjorde, based in Oslo, joined FSN Capital in 2018 as CFO, where he has played an important role in building structural capital in both the firm and in advising the FSN portfolio. Since April 2024, Knut has also led the FSN Execution Framework (FEF) team, a team of 20 in-house operating professionals. Knut is a member of the firm’s Portfolio Performance Committee (PPC) and Valuation Committee.

Robin Muerer and Ulrik Smith, Co-Managing Partners at FSN Capital, said: “Electing new partners is one of the most important decisions we take as a firm and as a partnership. For all promotions in the firm, we consider two dimensions: impact and values. In addition to their strong impact and contribution to the firm, all three new elected partners are true role models when it comes to living our firm values and leading their teams.”

 

About FSN Capital

Established in 1999, FSN Capital is a leading Northern European private equity firm and investment advisor to the FSN Capital Funds. FSN Capital has a team of more than 90 professionals across Oslo, Stockholm, Copenhagen, and Munich. Our ethos, “We are decent people making a decent return in a decent way” defines our core values.

The FSN Capital Funds have more than €4 billion under management and make control investments in growth-oriented Northern European companies, to support further growth and to transform companies into more sustainable, competitive, international, and profitable entities.  The FSN Funds are committed to being responsible investors and having a positive environmental and social impact across its portfolio while achieving market-leading returns. The FSN Funds are supported by 14 executive advisors with extensive industry experience.

Learn more about FSN on our website: www.fsncapital.com

Categories: People

Synova makes 7.3x return on the sale of InsurEvo

Synova Capital

Growth investor Synova is delighted to announce that an agreement has been reached for the sale of travel insurance data specialist, InsurEvo Group (including AllClear Insurance, InsureandGo, and JustCover; together “InsurEvo” or the “Group”), to US headquartered specialist insurance provider, NSM Insurance Group. The transaction, which remains subject to regulatory approval, will generate a return of 7.3x invested capital to Synova.

Following Synova’s investment, and under CEO Chris Rolland’s leadership, InsurEvo has transformed in scale and profitability, increasing revenues fivefold to £60m and placing £150m of GWP into the market this year, a sixfold increase in the investment period.

InsurEvo’s growth was delivered through a significant investment in best-of-breed technology, including actuarial AI, to capitalise on its unique data sets and the delivery of a highly effective multi-year sales and marketing strategy. Operating under the AllClear Insurance, InsureandGo and JustCover brands, the Group has provided cover to more than 4 million travellers, additionally allowing essential access to travel cover to people suffering from pre-existing medical conditions. InsurEvo employs over 350 staff across five offices in three countries, a near fourfold increase in employees since Synova’s investment.

Chris Rolland, CEO of InsurEvo, noted:

“I have enjoyed every minute of my partnership with Synova; their knowledge of our industry, their understanding of the building blocks of growth, and the discipline that comes from having a focused investor has been invaluable in accelerating the growth of the business.

“We’re absolutely thrilled to join forces with NSM to help us continue to grow and scale the business. Over the last two decades, our dedicated and talented team has helped us grow into the force we are today, and we look forward to extending that growth with NSM. NSM has the prowess and proven track record to help our business grow by expanding our distribution channels — further enhancing our technology platforms and expanding our global market reach. We are confident that NSM will lead to a bright future filled with growth, development, and success.”

David Menton, a Managing Partner of Synova and Non-Executive Director of InsurEvo Group, commented:

“The InsurEvo journey, in partnership with Chris Rolland, Cameron Jack, and their talented team, adds another chapter to Synova’s highly successful Financial Services story. The substantial scaling was achieved by harnessing AllClear’s strong reputation in the impaired travel market, its proprietary pricing database, and combining this with the vision of an experienced and ambitious leadership team.

Achieving these levels of growth, and generating outsized returns for our investors, was made more rewarding given InsurEvo’s clear social purpose. We remain grateful to the team, and to the Chair, Dr Ian Owen, for their energy and their vision, and wish them well on the next stage of their journey with Geof McKernan and his colleagues at NSM.”

Geof McKernan, CEO of NSM Insurance Group, said:

“Today marks an exciting new chapter for AllClear and InsureandGo. We are delighted to welcome these renowned brands to the NSM family,” said Geof McKernan, CEO & Founder of NSM Insurance Group. “Chris has done a tremendous job growing both brands and leading process and technological change while maintaining strong growth. Together, we will drive continued innovation to deliver exceptional value to our clients and expand our global presence.”

Categories: News

Tags: